CytoQuel: Clinical Documentation on Effects on Chronic Pain, Wellness, and Reduction of Inflammatory Markers
CompletedNot applicableNCT03690609
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose for this protocol is to perform an open-label parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical product on chronic pain, vascular health, inflammation, and overall wellness.
Study details
- Official title
- CytoQuel: Clinical Documentation on Effects on Chronic Pain, Wellness, and Reduction of Inflammatory Markers
- Conditions
- Interventions
- Dietary supplement: CytoQuel
- Dietary supplement: CytoQuel
- Sponsor
- Natural Immune Systems Inc
- Start date
- 2017-09-21
- Primary completion
- 2017-12-15
- Sex
- All
- Age range
- from 30 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult people of either gender; * Age 30-75 years (inclusive); * BMI between 20.0 and 34.9 (inclusive); * Experiencing chronic pain in at least one specific anatomical area for more than 6 months. Exclusion Criteria: * Active uncontrolled auto-immune disease (for example: rheumatoid arthritis, lupus, inflammatory bowel disease, Celiac disease); * Known active cardiovascular health issues; * Cancer during past 12 months; * Chemotherapy during past 12 months; * Currently taking blood pressure medication; * Currently taking blood thinning medication (81mg aspirin allowed); * Currently taking cholesterol-lowering medication (for example: statins); * Currently taking Coumadin; * Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product; * Currently taking prescription pain medications; * Getting regular joint injections (such as cortisone shots); * Major surgery within the past 3 months; * Major trauma within the past 3 months; * Any other condition or observation that the investigator judges may adversely affect the person's ability to complete the study; * Any other significant disease or disorder that the investigator judges may put the subject at risk because of participation in the study, or may influence the result of the study; * Hypersensitivity or known allergy to green tea or black tea; * Participation in another research study involving an investigational product in the past month; * Planned surgery within 2 weeks of completing the study; * Previous major surgery to stomach or intestines \[(absorption of test product may be altered) minor surgery is not a problem, including appendix and gallbladder removal\]; * Unwilling to maintain a constant intake of supplements over the duration of the study; * Women who are pregnant, nursing, or trying to become pregnant.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03690609